The 8051 was an 8-bit Harvard-architecture microcontroller first put out by Intel in 1980.  They’ve since discontinued that ...
I can't stand opening the Microsoft Store. It's slow to load, confusing to browse, and full of ads for things I don't care about. Luckily, thanks to a new feature, I don't have to open the Microsoft ...
Microsoft’s Edge browser includes a relatively new Copilot mode that brings AI directly into new tabs–but you’ve got to activate it first. Once enabled, Copilot adds an AI input window to new tabs, ...
Apple is bringing agentic coding to Xcode. On Tuesday, the company announced the release of Xcode 26.3, which will allow developers to use agentic tools, including Anthropic’s Claude Agent and ...
The latest update to OpenAI’s agentic browser improves memory usage and introduces support for tab groups. See what else is new. Since the release of ChatGPT Atlas last October, OpenAI has been ...
A hands-on test in VS Code showed Copilot using a degraded mockup image as the primary input to generate a working, navigation-capable web site, a significant step beyond last year's single-page ...
Is the Arduino Uno Q the missing piece in your next project? With its hybrid design that fuses the precision of a microcontroller with the flexibility of a Linux-based single-board computer, this ...
In a phase 1–2 trial, teclistamab, a bispecific antibody targeting CD3 on T-cell surfaces and B-cell maturation antigen on myeloma cells, showed durable responses in heavily pretreated patients with ...
Learn about the rules and cost-effective ways to combine multiple policies to meet changing life insurance insurance needs Written By Written by Insurance Staff Writer, WSJ | Buy Side Kimberly ...
Chrome’s new Split View feature allows me to have two tabs open simultaneously, side by side. We first heard about it at the beginning of the year, with users able to test it out in the browser by ...
For the first time, patients with abnormal cells detected in their bone marrow have a treatment option before the condition develops into multiple myeloma. The FDA has approved Johnson & Johnson’s ...